U.S. flag

An official website of the United States government

NM_002880.4(RAF1):c.856G>A (p.Glu286Lys) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Mar 13, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000586626.1

Allele description [Variation Report for NM_002880.4(RAF1):c.856G>A (p.Glu286Lys)]

NM_002880.4(RAF1):c.856G>A (p.Glu286Lys)

Gene:
RAF1:Raf-1 proto-oncogene, serine/threonine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p25.2
Genomic location:
Preferred name:
NM_002880.4(RAF1):c.856G>A (p.Glu286Lys)
HGVS:
  • NC_000003.12:g.12600394C>T
  • NG_007467.1:g.68786G>A
  • NM_001354689.3:c.916G>A
  • NM_001354690.3:c.856G>A
  • NM_001354691.3:c.613G>A
  • NM_001354692.3:c.613G>A
  • NM_001354693.3:c.757G>A
  • NM_001354694.3:c.673G>A
  • NM_001354695.3:c.514G>A
  • NM_002880.4:c.856G>AMANE SELECT
  • NP_001341618.1:p.Glu306Lys
  • NP_001341619.1:p.Glu286Lys
  • NP_001341620.1:p.Glu205Lys
  • NP_001341621.1:p.Glu205Lys
  • NP_001341622.1:p.Glu253Lys
  • NP_001341623.1:p.Glu225Lys
  • NP_001341624.1:p.Glu172Lys
  • NP_002871.1:p.Glu286Lys
  • NP_002871.1:p.Glu286Lys
  • LRG_413t1:c.856G>A
  • LRG_413t2:c.916G>A
  • LRG_413:g.68786G>A
  • LRG_413p1:p.Glu286Lys
  • LRG_413p2:p.Glu306Lys
  • NC_000003.11:g.12641893C>T
  • NM_002880.3:c.856G>A
  • NR_148940.3:n.1187G>A
  • NR_148941.3:n.1187G>A
  • NR_148942.3:n.1187G>A
Protein change:
E172K
Links:
dbSNP: rs147453956
NCBI 1000 Genomes Browser:
rs147453956
Molecular consequence:
  • NM_001354689.3:c.916G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354690.3:c.856G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354691.3:c.613G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354692.3:c.613G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354693.3:c.757G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354694.3:c.673G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354695.3:c.514G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002880.4:c.856G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_148940.3:n.1187G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148941.3:n.1187G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148942.3:n.1187G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000698131Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Mar 13, 2016)
germlineclinical testing

LabCorp Variant Classification Summary - May 2015.docx

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000698131.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: c.856G>A in RAF1 gene affects a highly conserved nucleotide, resulting in amino acid change from Glu to Lys. 3/4 in-silico tools predict this variant to be benign. The variant is found in the large control population datasets of ExAC and 1000Gs at an overall frequency of 0.00176% exclusively in individuals of East Asian origin. This frequency does not exceed the maximum expected allele frequency for a pathogenic RAF1 variant (0.0025%). The variant of interest has not, to our knowledge, been reported in affected individuals via publications or disease-specific databases/diagnostic centers. Taken together, the variant was classified as a variant of uncertain significance (VUS) until additional information becomes available.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024